RPL34P29

Across TCGA pan-cancer cohorts, RPL34P29 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPL34P29 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL34P29 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL34P29 expression acts as an unfavorable survival marker, although some lineages such as OV and KIRP show a favorable association.

KIRC, LIHC, and THYM are the cancer types where RPL34P29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.457	0.778	.004	72	view →
LIHC	OS	Tertile	All	0.367	0.782	<.001	72	view →
THYM	DFS	Tertile	All	0.091	0.884	<.001	36	view →
ESCA	OS	Tertile	II,III,IV	0.103	0.868	<.001	36	view →
LUSC	DFS	Tertile	II,III,IV	0.079	0.750	<.001	36	view →
SKCM	DFS	Tertile	III,IV	0.243	0.609	.004	33	view →
OV	OS	Tertile	IV	0.936	0.340	.014	30	view →
KIRP	DFS	Tertile	III,IV	1.000	0.335	.024	24	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	18	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	9	view →
LUAD	OS	Tertile	All	0.370	0.675	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPL34P29–KIRC (DFS)

Open the KIRC breakdown →